Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord. SE CONNECTER À UN COMPTE LECTEUR CRÉER UN COMPTE LECTEUR
Nokia and Samsung sign patent licensing agreement for video standards
11 mars 2021 01h00 HE
|
Nokia Oyj
Press Release Nokia and Samsung sign patent licensing agreement for video standards Agreement covers use of Nokia’s inventions in video standards 11 March 2021 Espoo, Finland –...
Press release Oncology Venture signs agreement to out-license two pipeline assets as part of prioritized portfolio strategy
29 juin 2020 02h30 HE
|
Oncology Venture A/S
Hørsholm, Denmark (29 June 2020) – Oncology Venture A/S (“OV” or the “Company”) today announced that it has signed a definitive agreement out-licensing two clinical pipeline assets, LiPlaCis® and...
Mateon Announces Achievement of Milestone Under Licensing of OT-101/IL-2 Combination to Autotelic BIO
10 juin 2020 08h00 HE
|
Mateon Therapeutics
The licensing agreement of OT-101 to Autotelic BIO with the field of use limited to OT-101 (Trabedersen) with Interleukin-2 (OT-101/IL-2) combination became effective this week with the completion of...
NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commercialization of NLG207
23 déc. 2019 16h05 HE
|
NewLink Genetics Corporation
AMES, Iowa, Dec. 23, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the company has entered into an exclusive worldwide license agreement with Ellipses...
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China
10 juil. 2019 16h01 HE
|
MacroGenics, Inc.
ROCKVILLE, MD, and SHANGHAI, China, July 10, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative...
ChromaDex Corp. and Nestlé Health Science Enter Global Commercial License and Supply Agreement for TRU NIAGEN®
20 déc. 2018 16h05 HE
|
ChromaDex Corporation
LOS ANGELES, Dec. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today it entered into a license and supply agreement with Nestlé Health Science (NHSc), a global leader...
The Premiere Group Acquires Derek Lam Beauty License
11 déc. 2018 09h05 HE
|
The Premiere Group
New York, New York, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Premiere Group, a wholly owned subsidiary of the Perfume Center of America Inc., has acquired the Derek Lam Beauty license, in a multi-year...
MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Margetuximab, MGD013 and TRIDENT™ Molecule in Greater China
29 nov. 2018 07h30 HE
|
MacroGenics, Inc.
Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing developmentExpand Zai Lab’s late-stage clinical pipeline with margetuximab and obtain rights to...
Arbutus Announces Corporate Update and First Quarter 2018 Financial Results
03 mai 2018 16h00 HE
|
Arbutus Biopharma Corporation
Two Novel HBV Candidates Planned to Enter Clinical Development in 2018GalNAc Conjugated RNAi Agent Nominated to Enter IND-Enabling Studies Strategic Partnership with Roivant to Launch Genevant, an RNA...
Apricus Biosciences Announces Outcome of Vitaros™ End-of-Review Meeting with FDA
16 avr. 2018 07h00 HE
|
Apricus Biosciences, Inc.
FDA Confirms Vitaros Regulatory Pathway Company Seeking Partner to Develop Vitaros in U.S. Company Evaluating Strategic Alternatives SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Apricus...